LENZ - LENZ Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$12.00
DETAILS
HIGH:
$12.00
LOW:
$12.00
MEDIAN:
$12.00
CONSENSUS:
$12.00
UPSIDE:
58.94%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 96.3% |
| EBIT Margin | -477.5% |
| EBITDA Margin | -476.0% |
| Operating Margin | -477.5% |
| Pretax Margin | -427.6% |
| Cont. Ops Margin | -430.3% |
| Net Margin | -430.3% |
| Bottom Line Margin | -430.3% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 13.80 |
| Quick Ratio | 13.80 |
| Solvency Ratio | -3.800 |
| Cash Ratio | 1.19 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-5.61
Peers avg: 50.1
|
| PEG Ratio | -0.26 |
| Forward PEG | -0.26 |
| Price/Book | 1.62 |
| Price/Sales | 24.15 |
| Price/FCF | -6.59 |
| Price/Op Cash Flow | -6.66 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0011 |
| Debt/Equity | 0.0012 |
| Debt/Capital | 0.0012 |
| Long-Term Debt/Capital | 0.0012 |
| Financial Leverage | 1.08 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.08 |
| Operating Cash Flow Ratio | -3.265 |
| Operating Cash Flow/Sales | -362.4% |
| Free Cash Flow/Operating Cash Flow | 101.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -197.63 |
| Capital Expenditure Coverage | -83.64 |
| Dividend + Capital Expenditure Coverage | -83.64 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.66 |
| EPS | -2.850 |
| Debt/Share | 0.0121 |
| Cash/Share | 10.15 |
| Book Value/Share | 9.87 |
| Tangible BV/Share | 9.87 |
| Equity/Share | 9.87 |
| Operating Cash Flow/Share | -2.401 |
| Capital Expenditure/Share | 0.029 |
| FCF/Share | -2.429 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.006 |
| Earnings Before Tax/EBIT | 0.896 |
| Price/Fair Value | 1.62 |
| Debt/Market Cap | 0.0008 |
| Effective Tax Rate | -0.6% |
| Enterprise Value Multiple | -4.80 |